Cited by 536Genomics and Chromatin DynamicsCRISPR and Genetic EngineeringGenetic Associations and Epidemiology

Massively parallel functional dissection of mammalian enhancers in vivo

Open access
Patwardhan, Rupali P, Hiatt, Joseph B, Witten, Daniela M, Kim, Mee J, Smith, Robin P, May, Dalit, Lee, Choli, Andrie, Jennifer M +5 more·2012·Nature Biotechnology

Abstract

The functional consequences of genetic variation in mammalian regulatory elements are poorly understood. We report the in vivo dissection of three mammalian enhancers at single-nucleotide resolution through a massively parallel reporter assay. For each enhancer, we synthesized a library of >100,000 mutant haplotypes with 2-3% divergence from the wild-type sequence. Each haplotype was linked to a unique sequence tag embedded within a transcriptional cassette. We introduced each enhancer library into mouse liver and measured the relative activities of individual haplotypes en masse by sequencing the transcribed tags. Linear regression analysis yielded highly reproducible estimates of the effect of every possible single-nucleotide change on enhancer activity. The functional consequence of most mutations was modest, with ∼22% affecting activity by >1.2-fold and ∼3% by >2-fold. Several, but not all, positions with higher effects showed evidence for purifying selection, or co-localized with known liver-associated transcription factor binding sites, demonstrating the value of empirical high-resolution functional analysis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nbt.2136

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DeepLiver predictions of the effect of enhancer mutations correlate with experimental saturation mutagenesis data on six enhancers from earlier studies (correlation ranging between 0.36 and 0.75).

    “DeepLiver predictions of the effect of enhancer mutations correlate with experimental results (with a correlation ranging between 0.36 and 0.75; Extended Data Fig. 7f).”

    From Single-cell spatial multi-omics and deep learning dissect enhancer-driven gene regulatory networks in liver zonation (2024) · cites this paper as [41]

    The Abstract and Results section report experimental saturation-mutagenesis measurements of mutation effects for three mammalian liver enhancers, so this paper supports the identification of an earlier experimental dataset. It does not report six enhancers or a comparison with DeepLiver predictions; the correlations of 0.36–0.75 are not established by this source. Page numbers are not available in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • DeepLiver in silico mutagenesis was validated by calculating the correlation between the effect of mutations predicted by DeepLiver and experimental saturation mutagenesis data on six enhancers from earlier studies (three in vivo, three HepG2).

    “To validate DeepLiver in silico mutagenesis, we calculated the correlation between the effect of the mutations predicted by DeepLiver and experimental saturation mutagenesis data on six enhancers from earlier studies (three enhancers from in vivo studies and three enhancers from HepG2 cells)41,42.”
  • Massively Parallel Reporter Assays have been established to directly test and identify active enhancers.

    “new experimental approaches, such as Massively Parallel Reporter Assays (MPRAs), have been established to directly test and identify active enhancers14–18.”
  • DeepLiver in silico mutagenesis was validated by calculating the correlation between predicted mutation effects and experimental saturation mutagenesis data on six enhancers from earlier studies (three in vivo and three HepG2).

    “To validate DeepLiver in silico mutagenesis, we calculated the correlation between the effect of the mutations predicted by DeepLiver and experimental saturation mutagenesis data on six enhancers from earlier studies (three enhancers from in vivo studies and three enhancers from HepG2)14,60.”
  • DeepLiver in silico mutagenesis correlates with experimental saturation mutagenesis in the AldoB enhancer.

    “Correlation between DeepLiver in silico mutagenesis and experimental saturation mutagenesis in the AldoB enhancer.”

    From Enhancer grammar of liver cell types and hepatocyte zonation states (2022) · cites this paper as Patwardhan et al., 2012

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 23

  1. [1]Consortium EP A user’s guide to the encyclopedia of DNA elements (ENCODE) PLoS Biol 9 e1001046 2011 21526222 PMC3079585
  2. [2]Ernst J Mapping and analysis of chromatin state dynamics in nine human cell types Nature 473 43 49 2011 21441907 PMC3088773
  3. [3]Visel A ChIP-seq accurately predicts tissue-specific activity of enhancers Nature 457 854 858 2009 19212405 PMC2745234
  4. [4]Cooper GM Shendure J Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data Nat Rev Genet 12 628 640 2011 21850043
  5. [5]Kleinjan DA van Heyningen V Long-range control of gene expression: emerging mechanisms and disruption in disease Am J Hum Genet 76 8 32 2005 15549674 PMC1196435
  6. [6]Noonan JP McCallion AS Genomics of long-range regulatory elements Annu Rev Genomics Hum Genet 11 1 23 2010 20438361
  7. [7]VanderMeer JE Ahituv N cis-regulatory mutations are a genetic cause of human limb malformations Dev Dyn 240 920 930 2011 21509892 PMC3174732
  8. [9]Sabourin JC An intronic enhancer essential for tissue-specific expression of the aldolase B transgenes J Biol Chem 271 3469 3473 1996 8631949
  9. [10]Gregori C Expression of the rat aldolase B gene: a liver-specific proximal promoter and an intronic activator Biochem Biophys Res Commun 176 722 729 1991 2025285
  10. [11]Gregori C Porteu A Mitchell C Kahn A Pichard AL In vivo functional characterization of the aldolase B gene enhancer J Biol Chem 277 28618 28623 2002 12034748
  11. [12]Kim MJ Functional characterization of liver enhancers that regulate drug-associated transporters Clinical pharmacology and therapeutics 89 571 578 2011 21368754 PMC3227682
  12. [13]Dang Q Structure of the hepatic control region of the human apolipoprotein E/C-I gene locus J Biol Chem 270 22577 22585 1995 7673250
  13. [14]Patwardhan RP High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis Nat Biotechnol 27 1173 1175 2009 19915551 PMC2849652
  14. [15]Hiatt JB Patwardhan RP Turner EH Lee C Shendure J Parallel, tag-directed assembly of locally derived short sequence reads Nature methods 7 119 122 2010 20081835 PMC2848820
  15. [16]Zhang G Budker V Wolff JA High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA Hum Gene Ther 10 1735 1737 1999 10428218
  16. [17]Kel AE MATCH: A tool for searching transcription factor binding sites in DNA sequences Nucleic acids research 31 3576 3579 2003 12824369 PMC169193
  17. [18]Loots GG Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons Science 288 136 140 2000 10753117
  18. [19]Margulies EH Analyses of deep mammalian sequence alignments and constraint predictions for 1% of the human genome Genome Res 17 760 774 2007 17567995 PMC1891336
  19. [20]Visel A Ultraconservation identifies a small subset of extremely constrained developmental enhancers Nat Genet 40 158 160 2008 18176564 PMC2647775
  20. [21]Blow MJ ChIP-Seq identification of weakly conserved heart enhancers Nat Genet 42 806 810 20729851 PMC3138496
  21. [22]Schmidt D Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding Science 328 1036 1040 2010 20378774 PMC3008766
  22. [23]Cooper GM Distribution and intensity of constraint in mammalian genomic sequence Genome Res 15 901 913 2005 15965027 PMC1172034
  23. [25]Botstein D Shortle D Strategies and applications of in vitro mutagenesis Science 229 1193 1201 1985 2994214

Cited by

Sorted by citations

Authors
Patwardhan, R. P., Hiatt, J. B., Witten, D. M., Kim, M. J., Smith, R. P., May, D., Lee, C., Andrie, J. M., Lee, S.-I., Cooper, G. M., Ahituv, N., Pennacchio, L. A., & Shendure, J.
Affiliations
  • University of Washington (US)
  • University of California, San Francisco (US)
  • Lawrence Berkeley National Laboratory (US)
  • HudsonAlpha Institute for Biotechnology (US)
Corresponding author
  • Ahituv, Nadav
  • Pennacchio, Len A
  • Shendure, Jay
Venue
Nature Biotechnology
Published
2012-02-26
Volume
30
Issue
3
Pages
265-270
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W1989004527
Cited by
536
References
2
Citations by year
2026: 26 · 2025: 41 · 2024: 19 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 34 · 2019: 41 · 2018: 40 · 2017: 43 · 2016: 51 · 2015: 57 · 2014: 43 · 2013: 34 · 2012: 22
FWCI
20.07
Type
journal article
Language
en
Open access
Locations
  • Nature Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (DP5OD009145)
  • National Institute on Aging (F30AG039173)
  • National Human Genome Research Institute (R01HG003988)
  • National Institute of General Medical Sciences (U19GM061390, T32GM007175, U01GM061390)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK026743)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD059862)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
enhancer function, single nucleotide variants, massively parallel reporter assay, mouse liver, purifying selection, transcription factor binding sites
MeSH terms
Animals, Binding Sites, Enhancer Elements, Genetic, Haplotypes, Humans, Liver, Mutation, Transcription Factors, Transcription, Genetic, Linear Models, Mutagenesis, Genes, Reporter, Evolution, Molecular, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review